Literature DB >> 33618555

Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study.

Joppe Oldenburg1, Matteo Malinverno2, Maria Ascencion Globisch1, Claudio Maderna2, Monica Corada2, Fabrizio Orsenigo2, Lei Liu Conze1, Charlotte Rorsman1, Veronica Sundell1, Maximiliano Arce1, Ross O Smith1, Anthony C Y Yau1, Gry Hulsart Billström3, Caroline Öhman Mägi4, Galina V Beznoussenko2,5, Alexander A Mironov5, Dinesh Fernando6, Geoffrey Daniel6, Davide Olivari7, Francesca Fumagalli7, Maria Grazia Lampugnani2,8, Elisabetta Dejana1,2,9, Peetra U Magnusson1.   

Abstract

[Figure: see text].

Entities:  

Keywords:  cavernous; central nervous system; endothelial cells; pericytes; propranolol; vascular malformations

Mesh：

Substances：

Year:  2021        PMID： 33618555     DOI： 10.1161/STROKEAHA.120.029676

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


  8 in total

1.  A 5-year outcome of propranolol for the treatment of paediatric intracranial cavernoma: case report and a review of the literature.

Authors:  Jakov Tiefenbach; Jay J Park; Chandrasekaran Kaliaperumal
Journal:  Childs Nerv Syst       Date:  2022-07-14       Impact factor: 1.532

Review 2.  Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.

Authors:  Chelsea M Phillips; Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 3.  The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases.

Authors:  Angel M Cuesta; Eunate Gallardo-Vara; Juan Casado-Vela; Lucía Recio-Poveda; Luisa-María Botella; Virginia Albiñana
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.

Authors:  Wenqing Li; Virginia Tran; Iftach Shaked; Belinda Xue; Thomas Moore; Rhonda Lightle; David Kleinfeld; Issam A Awad; Mark H Ginsberg
Journal:  Elife       Date:  2021-05-20       Impact factor: 8.140

5.  A murine model of cerebral cavernous malformations with acute hemorrhage.

Authors:  Claudio Maderna; Federica Pisati; Claudio Tripodo; Elisabetta Dejana; Matteo Malinverno
Journal:  iScience       Date:  2022-02-18

6.  Propranolol as therapy for cerebral cavernous malformations: a cautionary note.

Authors:  Douglas A Marchuk; Issam A Awad; Robert Shenkar; Thomas Moore; Christian Benavides; Rhonda Lightle; Matthew R Detter; Nicholas Hobson; Romuald Girard; Dorothy DeBiasse; Mary Patrucco; Carol Gallione; Joseph M Zabramski
Journal:  J Transl Med       Date:  2022-04-05       Impact factor: 5.531

Review 7.  Atlas of Nervous System Vascular Malformations: A Systematic Review.

Authors:  Carlos Castillo-Rangel; Gerardo Marín; Karla Aketzalli Hernandez-Contreras; Cristofer Zarate-Calderon; Micheel Merari Vichi-Ramirez; Wilmar Cortez-Saldias; Marco Antonio Rodriguez-Florido; Ámbar Elizabeth Riley-Moguel; Omar Pichardo; Osvaldo Torres-Pineda; Helena G Vega-Quesada; Ramiro Lopez-Elizalde; Jaime Ordoñez-Granja; Hugo Helec Alvarado-Martinez; Luis Andrés Vega-Quesada; Gonzalo Emiliano Aranda-Abreu
Journal:  Life (Basel)       Date:  2022-08-07

8.  Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Authors:  Anthony C Y Yau; Maria Ascencion Globisch; Favour Chinyere Onyeogaziri; Lei L Conze; Ross Smith; Suvi Jauhiainen; Monica Corada; Fabrizio Orsenigo; Hua Huang; Melanie Herre; Anna-Karin Olsson; Matteo Malinverno; Veronica Sundell; Behnam Rezai Jahromi; Mika Niemelä; Aki Laakso; Cecilia Garlanda; Alberto Mantovani; Maria Grazia Lampugnani; Elisabetta Dejana; Peetra U Magnusson
Journal:  Cell Mol Life Sci       Date:  2022-03-25       Impact factor: 9.207
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.